Literature DB >> 26724994

Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling.

Cameron L Noland1, Sarah Gierke2, Paul D Schnier3, Jeremy Murray1, Wendy N Sandoval3, Meredith Sagolla2, Anwesha Dey4, Rami N Hannoush5, Wayne J Fairbrother6, Christian N Cunningham7.   

Abstract

The Hippo signaling pathway is responsible for regulating the function of TEAD family transcription factors in metazoans. TEADs, with their co-activators YAP/TAZ, are critical for controlling cell differentiation and organ size through their transcriptional activation of genes involved in cell growth and proliferation. Dysregulation of the Hippo pathway has been implicated in multiple forms of cancer. Here, we identify a novel form of regulation of TEAD family proteins. We show that human TEADs are palmitoylated at a universally conserved cysteine, and report the crystal structures of the human TEAD2 and TEAD3 YAP-binding domains in their palmitoylated forms. These structures show a palmitate bound within a highly conserved hydrophobic cavity at each protein's core. Our findings also demonstrate that this modification is required for proper TEAD folding and stability, indicating a potential new avenue for pharmacologically regulating the Hippo pathway through the modulation of TEAD palmitoylation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26724994     DOI: 10.1016/j.str.2015.11.005

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  55 in total

Review 1.  Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine.

Authors:  Anwesha Dey; Xaralabos Varelas; Kun-Liang Guan
Journal:  Nat Rev Drug Discov       Date:  2020-06-17       Impact factor: 84.694

Review 2.  YAP/TAZ Signaling and Resistance to Cancer Therapy.

Authors:  Chan D K Nguyen; Chunling Yi
Journal:  Trends Cancer       Date:  2019-03-27

3.  Palmitoylation stabilizes PD-L1 to promote breast tumor growth.

Authors:  Yi Yang; Jung-Mao Hsu; Linlin Sun; Li-Chuan Chan; Chia-Wei Li; Jennifer L Hsu; Yongkun Wei; Weiya Xia; Junwei Hou; Yufan Qiu; Mien-Chie Hung
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

Review 4.  Advances in targeting 'undruggable' transcription factors with small molecules.

Authors:  Matthew J Henley; Angela N Koehler
Journal:  Nat Rev Drug Discov       Date:  2021-05-18       Impact factor: 84.694

Review 5.  Protein palmitoylation and cancer.

Authors:  Pin-Joe Ko; Scott J Dixon
Journal:  EMBO Rep       Date:  2018-09-19       Impact factor: 8.807

6.  The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.

Authors:  Ayumi Kaneda; Toshihiro Seike; Tomohiro Danjo; Takahiro Nakajima; Nobumasa Otsubo; Daisuke Yamaguchi; Yoshiro Tsuji; Kaori Hamaguchi; Mai Yasunaga; Yoichi Nishiya; Michihiko Suzuki; Jun-Ichi Saito; Rie Yatsunami; Satoshi Nakamura; Yoshitaka Sekido; Kiyotoshi Mori
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

7.  DNA-binding mechanism of the Hippo pathway transcription factor TEAD4.

Authors:  Z Shi; F He; M Chen; L Hua; W Wang; S Jiao; Z Zhou
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

8.  Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity.

Authors:  Nam-Gyun Kim; Barry M Gumbiner
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-01       Impact factor: 11.205

Review 9.  Fatty acylation of proteins: The long and the short of it.

Authors:  Marilyn D Resh
Journal:  Prog Lipid Res       Date:  2016-05-24       Impact factor: 16.195

10.  Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3.

Authors:  Wei Zhou; Yiping Li; Jinhua Song; Chenglong Li
Journal:  Anal Biochem       Date:  2019-08-31       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.